DarioHealth Reports Results For Second Quarter 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
DarioHealth (DRIO) Reports In-Line Q2 EPS, Revenues Miss
August 13, 2019 6:23 AM EDTDarioHealth (NASDAQ: DRIO) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $1.65 million versus the consensus estimate of $2.45 million.
Q2 2019 Revenue of $1.65 million, a 20% decline from Q2 2018Record 1H 2019 Revenue of $3.89 million, a 2% increase over 1H 2018Expense shift from D2C to B2B, resulting in a short-term decline in Revenue and an expectation of significant reductions to Net loss in 2H 2019 Significantly advanced key 2019 initiative to expand growth strategy solely from the direct-to-consumer (D2C) channel to include the more scalable,... More